Trial Profile
Alendronic acid +/- colecalciferol in postmenopausal women with osteoporosis: effects on levels of parathyroid hormone and bone turnover markers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2013
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Alendronic acid
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 10 Jan 2013 New trial record